| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 14 Feb 2025 | 6 Feb 2025 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve DEcember Quarterly financial result outcome (As Per Bse Announcement Dated on 14.02.2025) | ||
| Board Meeting | 2 Jan 2025 | 2 Jan 2025 |
| Reg 30 of SEBI (Listing Obligation and Disclosure Requirements)- Resignation of Company Secretary | ||
| Board Meeting | 4 Dec 2024 | 29 Nov 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/12/2024 inter alia to consider and approve Raising funds by way of Preferential issue of shares or warrants or any other method Outcome (As per BSE Announcement Dated on 04/12/2024) | ||
| Board Meeting | 29 Nov 2024 | 26 Nov 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/11/2024 inter alia to consider and approve Preferential issue or any other matter outcome (As Per BSE Announcement Dated on 29.11.2024) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Financial result for september 2024 Outcome (As per BSE Announcement dated on 14/11/2024) | ||
| Board Meeting | 1 Oct 2024 | 25 Sep 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2024 inter alia to consider and approve Allotment Outcome (As Per BSE Announcement Dated on: 01/10/2024) | ||
| Board Meeting | 14 Aug 2024 | 6 Aug 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited Financial Result for June 2024 outcome (As per BSE Announcement Dated on 14/08/2024) | ||
| Board Meeting | 30 May 2024 | 23 May 2024 |
| AAREY DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve Financial Audited Result of March 2024 outcome (As Per BSE Announcement Dated on 30.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
